Evidence map›Paper›PMID 37175007›Full record

ArticleDiagnostics (Basel, Switzerland)2023

Chest CT Findings after Mild COVID-19 Do Not Explain Persisting Respiratory Symptoms: An Explanatory Study.

Stefan Malesevic, Noriane A Sievi, Jonas Herth, Felix Schmidt, Dörthe Schmidt, Florence Vallelian, Ilijas Jelcic, Lisa Jungblut, Thomas Frauenfelder, Malcolm Kohler and 2 more

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Pulmonary manifestations of long COVID in Johannesburg, South Africa.Southern African journal of infectious diseases · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Stefan MalesevicFaculty of Medicine, University of Zurich, 8006 Zurich, Switzerland.
Noriane A SieviDepartment of Pulmonology, University Hospital Zurich, 8091 Zurich, Switzerland.ORCID 0000-0003-1758-4586
Jonas HerthFaculty of Medicine, University of Zurich, 8006 Zurich, Switzerland.
Felix SchmidtFaculty of Medicine, University of Zurich, 8006 Zurich, Switzerland.
Dörthe SchmidtDepartment of Cardiology, University Hospital Zurich, 8091 Zurich, Switzerland.
Florence VallelianDepartment of Internal Medicine, University Hospital Zurich, 8091 Zurich, Switzerland.ORCID 0000-0001-9659-8278
Ilijas JelcicDepartment of Neurology, University Hospital Zurich, 8091 Zurich, Switzerland.
Lisa JungblutInstitute of Diagnostic and Interventional Radiology, University Hospital Zurich, 8091 Zurich, Switzerland.
Thomas FrauenfelderFaculty of Medicine, University of Zurich, 8006 Zurich, Switzerland.ORCID 0000-0002-3295-6619
Malcolm KohlerFaculty of Medicine, University of Zurich, 8006 Zurich, Switzerland.
Katharina MartiniInstitute of Diagnostic and Interventional Radiology, University Hospital Zurich, 8091 Zurich, Switzerland.
Christian F ClarenbachFaculty of Medicine, University of Zurich, 8006 Zurich, Switzerland.ORCID 0000-0003-2158-2321
University Hospital of Zurich · CHUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: Lung tissue involvement is frequently observed in acute COVID-19. However, it is unclear whether CT findings at follow-up are associated with persisting respiratory symptoms after initial mild or moderate infection. (2) Methods: Chest CTs of patients with persisting respiratory symptoms referred to the post-COVID-19 outpatient clinic were reassessed for parenchymal changes, and their potential association was evaluated. (3) Results: A total of 53 patients (31 female) with a mean (SD) age of 46 (13) years were included, of whom 89% had mild COVID-19. Median (quartiles) time from infection to CT was 139 (86, 189) days. Respiratory symptoms were dyspnea (79%), cough (42%), and thoracic pain (64%). Furthermore, 30 of 53 CTs showed very discrete and two CTs showed medium parenchymal abnormalities. No severe findings were observed. Mosaic attenuation (40%), ground glass opacity (2%), and fibrotic-like changes (25%) were recorded. No evidence for an association between persisting respiratory symptoms and chest CT findings was found. (4) Conclusions: More than half of the patients with initially mild or moderate infection showed findings on chest CT at follow-up. Respiratory symptoms, however, were not related to any chest CT finding. We, therefore, do not suggest routine chest CT follow-up in this patient group if no other indications are given.

Indexed as

chest CTpost-COVID-19respiratory symptoms

Identifiers

PMID37175007
PMCPMC10178158
OpenAlexW4368367310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.